Journal Article

FZJ-2025-04520

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Sulfite oxidase deficiency causes persulfidation loss and hydrogen sulfide release

Fu, C.-Y. ; Kohl, J. B. ; Liebsch, F. ; D’Andrea, D. ; Ditrói, T. ; Ogata, S. ; Neuser, F. ; Mai, M. ; Mellis, A. T. ; Kouroussis, E. ; Morita, M. ; Gehling, T. ; Santamaria-Araujo, J. A. ; Yeo, S. Y. ; Endepols, H.FZJ* ; Křížková, M. ; Kozich, V. ; Krueger, M. ; Hennermann, J. B. ; Barayeu, U. ; Akaike, T. ; Nagy, P. ; Filipovic, M. ; Schwarz, G. (Corresponding author)

2025
ASCJ Ann Arbor, Mich.

This record in other databases:  

Please use a persistent id in citations: doi:10.1172/JCI181299  doi:10.34734/FZJ-2025-04520

Abstract: Sulfite oxidase (SOX) deficiency is a rare inborn error of cysteine metabolism resulting in severe neurological damage. In patients, sulfite accumulates to toxic levels, causing a rise in the downstream products S-sulfocysteine, which mediates excitotoxicity, and thiosulfate, a catabolic intermediate/product of hydrogen sulfide (H2S) metabolism. Here, we report a full-body knockout mouse model for SOX deficiency (SOXD) with a severely impaired phenotype. Among the urinary biomarkers, thiosulfate showed a 45-fold accumulation in SOXD mice, representing the major excreted S-metabolite. Consistently, we found increased plasma H2S, which was derived from sulfite-induced release from persulfides, as demonstrated in vitro and in vivo. Mass spectrometry analysis of total protein persulfidome identified a major loss of S-persulfidation in 20% of the proteome, affecting enzymes in amino acids, fatty acid metabolism, and cytosolic iron-sulfur cluster biogenesis. Urinary amino acid profiles indicated metabolic rewiring and mitochondrial dysfunction, thus identifying an altered H2S metabolism and persulfidation in SOXD. Finally, oxidized glutathione and glutathione trisulfide were able to scavenge sulfite in vitro and in vivo, extending the lifespan of SOXD mice and providing a mechanistic concept of sulfite scavenging for the treatment of this severe metabolic disorder of cysteine catabolism.

---

Contributing Institute(s):

1. Nuklearchemie (INM-5)

Research Program(s):

1. 5253 - Neuroimaging (POF4-525) (POF4-525)

Appears in the scientific report 2025

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---